R-eriodictyol and S-eriodictyol exhibited comparable effect against H2O2-induced oxidative stress in EA.hy926 cells

Drug Discoveries & Therapeutics

Volumn 8, Issue 5, 2011, Pages 218-224

  Li, Haizhen ^a   Li, Chao ^a   Shen, Tao ^a   Zhao, Lijuan ^a   Ren, Dongmei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

cytoprotective activity; enantiomer; Eriodictyol; oxidative stress

Indexed keywords

ERIODICTYOL; FLAVANONE DERIVATIVE; HYDROGEN PEROXIDE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECTS; HUMAN; METABOLISM; OXIDATIVE STRESS; STEREOISOMERISM;

APOPTOSIS; CELL LINE; CELL SURVIVAL; FLAVANONES; HUMANS; HYDROGEN PEROXIDE; OXIDANTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STEREOISOMERISM;

EID: 84924953979     PISSN: 18817831     EISSN: 1881784X     Source Type: Journal    
DOI: 10.5582/ddt.2014.01033     Document Type: Article

References (22)

1. Rossato MF, Trevisan G, Walker CI, Klafke JZ, de Oliveira AP, Villarinho JG, Zanon RB, Royes LF, Athayde ML, Gomez MV, Ferreira J. Eriodictyol: a flavonoid antagonist of the TRPV1 receptor with antioxidant activity. Biochem Pharmacol. 2011; 81: 544-551.
2. Lee E, Jeong KW, Shin A, Jin B, Jnawali HN, Jun BH, Lee JY, Heo YS, Kim Y. Binding model for eriodictyol to Jun-N terminal kinase and its anti-inflammatory signaling pathway. BMB Rep. 2013; 46: 594-599.
3. Mandalari G, Bennett RN, Bisignano G, Trombetta D, Saija A, Faulds CB, Gasson MJ, Narbad A. Antimicrobial activity of flavonoids extracted from bergamot (Citrus bergamia Risso) peel, a byproduct of the essential oil industry. J Appl Microbiol. 2007; 103: 2056-2064.
4. Le, ER, Kim JH, Choi HY, Jeon K, Cho SG. Cytoprotective effect of eriodictyol in UV-irradiated keratinocytes via phosphatase-dependent modulation of both the p38 MAPK and Akt signaling pathways. Cell Physiol Biochem. 2011; 27: 513-524.
5. Johnson J, Maher P, Hanneken A. The flavonoid, eriodictyol, induces long-term protection in ARPE-19 cells through its effects on Nrf2 activation and phase 2 gene expression. Invest Ophthalmol Vis Sci. 2009; 50: 2398-2406.
6. Lou H, Jing X, Ren D, Wei X, Zhang X. Eriodictyol protects against H2O2-induced neuron-like PC12 cell death through activation of Nrf2/ARE signaling pathway. Neurochem Int. 2012; 61: 251-257.
7. Zhang WY, Lee JJ, Kim Y, Kim IS, Han JH, Lee, SG, Ahn MJ, Jung SH, Myung CS. Effect of eriodictyol on glucose uptake and insulin resistance in vitro. J Agric Food Chem. 2012; 60: 7652-7658.
8. Bucolo C, Leggio GM, Drago F, Salomone S. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocininduced diabetic rats. Biochem Pharmacol. 2012; 84: 88-92.
9. Brocks DR. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharm Drug Dispos. 2006; 27: 387-406.
10. Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H. Identification of a primary target of thalidomide teratogenicity. Science. 2010; 327: 1345-1350.
11. Tomassoni D, Amenta F, Amantini C, Farfariello V, Mannelli LDC, Nwankwo IE, Marini C, Tayebati Sk. Brain activity of thioctic acid enantiomers: in vitro and in vivo studies in an animal model of cerebrovascular injury. Int. J. Mol. Si. 2013; 14: 4580-4595.
12. Gaggeri R, Rossi D, Daglia M, Leoni F, Avanzini MA, Manellic M, Juza M, Collina S. An eco-friendly enantioselective access to (R)-naringenin as inhibitor of proinflammatory cytokine release. Chem. Biodivers. 2013; 10: 1531-1538.
13. Yanez JA, Remsberg CM, Miranda ND, Vega-Villa KR, Andrews PK, Davies NM. Pharmacokinetics of selected chiral flavonoids: hesperetin, naringenin and eriodictyol in rats and their content in fruit juices. Biopharm. Drug Dispos. 2008; 29: 63-82.
14. Jeon Y, Kwon C, Cho E, Jung S. Carboxymethylated cyclosophoraose as a novel chiral additive for the stereoisomeric separation of some flavonoids by capillary electrophoresis. Carbohydr Res. 2010; 345: 2408-2412.
15. Asztemborska M, Miskiewicz M, Sybilska D. Separation of some chiral flavanones by micellar electrokinetic chromatography. Electrophoresis. 2003; 24: 2527-2531.
16. Caccamese S, Caruso C, Parrinello N, Savarino A. High-performance liquid chromatographic separation and chiroptical properties of the enantiomers of naringenin and other flavanones. J Chromatogr A. 2005; 1076: 155-162.
17. Guo X, Li C, Duan L, Zhao L, Lou H, Ren D. Separation of the enantiomers of naringenin and eriodictyol by amylose-based chiral reversed-phase high-performance liquid chromatography. Drug Discov Ther. 2012; 6: 321-326.
18. Ren D, Yuan J. Studies on the chemical constituents of Dracocephalum rupestre. Zhong Cao Yao. 1997; 28: 74-76.
19. Wang XJ, Sun Z, Chen W, Eblin KE, Gandolfi JA, Zhang DD. Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol Appl Pharmacol. 2007; 225: 206-213.
20. Hu Q, Zhang DD, Wang L, Lou H, Ren D. Eriodictyol-7-O-glucoside, a novel Nrf2 activator, confers protection against cisplatin-induced toxicity. Food Chem Toxicol. 2012; 50: 1927-1932.
21. Urcan E, Haertel U, Styllou M, Hickel R, Scherthan H, Reichl FX. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dent Mater. 2010; 26: 51-58.
22. Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, Zhang DD, The protective role of Nrf2 in streptozotocininduced diabetic nephropathy. Diabetes. 2010; 59: 850-860.